Clinical Trial Update: A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the effect of esomeprazole on the pharmacokinetics of lapatinib in patients with metastatic HER2-positive breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED